Ketogenic diet improves metabolic markers, shows promise for bipolar disorder and schizophrenia symptoms in first RCT, partly funded by Baszucki Group ...

Shape Memory Medical Inc., developer of the only commercially available volume‑expanding shape memory polymer for endovascular embolization, announced today that it has completed enrollment in the AAA ...

Summary: Researchers demonstrated that a ketogenic diet, which shifts the body away from glucose and toward fat-derived ketones for fuel, induces rapid metabolic improvements and alleviates persistent ...

Shape Memory Medical Inc., developer of a commercially available volume-expanding shape memory polymer for endovascular embolizatio ...

July 8, 2026 expert reaction to RCT on efficacy of anti-histamines, anti-inflammatory, and blood thinner drugs on long Covid-related fatigue . A randomised controlled trial publis ...

Outcomes of the HeartMate 3 device vary by age, with younger patients showing better survival and less bleeding events and ...

Published today in Schizophrenia Bulletin, a first-of-its-kind randomized controlled trial (RCT) from researchers at the ...

Creatine, the common muscle-building supplement, may help improve depression symptoms, new research suggests. A systematic ...

Patients Enrolled Across Sites in the United States and Australia, Advancing the Path to FDA Approval of a Novel Endoscopic Treatment for Type 2 Diabetes ...

Q: Is President Trump the anonymous 79-year-old man getting a still-unapproved obesity drug via a Food and Drug ...

(Nasdaq: IMNM), a biotechnology company committed to developing first-in-class and best-in-class targeted cancer therapies, today announced the U.S. Food and Drug Administration (FDA or the Agency) ...

Despite substantial weight loss, most obesity drugs such as Wegovy and Mounjaro do not meaningfully improve quality of life, ...